Getinge Infection Control enters into low temperature market with acquisition of Stericool and exclusive distribution agreement with TSO3

Getinge Group’s business area Infection Control, a global leader in infection
control and contamination prevention solutions, has acquired Stericool, a
Turkish company specializing in low temperature sterilization, and also signed
an exclusive global distribution agreement with Canadian company TSO3 Inc., an
innovator in sterilization technology for medical devices. The acquisition and
distribution agreement are in line with Getinge’s strategy to strengthen
customer offerings with new innovations and to offer a product range for
different markets.

“Today’s announcement marks a major milestone in Getinge’s latest offerings to
our customers. As a global leader in infection control, Getinge has a unique
opportunity not only to enter into the fast growing low temperature
sterilization market, but also to leverage our legacy of excellence as a
complete solutions provider,” says Joacim Lindoff, Executive Vice President of
Infection Control.

The minimally invasive surgery (MIS) market is a leading indicator of growth for
the low temperature sterilization market. The instruments used in such surgeries
are extremely sensitive to the high temperatures and pressure of a steam
sterilization process. As the minimally invasive surgery market continues to
grow at an expected compound annual growth rate of 10 %*, demands for
alternatives to steam sterilizers will also increase thereby providing great
potential for accelerated business growth within infection control. Estimation
on the annual replacement and new business worldwide for low temperature
sterilizers totals more than 2,300 units or approximately 1,7 BSEK.

* Figure based on a recent study by Transparency Market Research (TMR), a market
intelligence firm based in the United States.

Acquisition of Stericool

Founded in 2008, Stericool has its headquarters and manufacturing site in
Ankara, Turkey, with a total of 20 employees. Its sales are expected to total 20
MSEK in the current calendar year. The company manufactures hydrogen peroxide
based solution low temperature sterilizers for emerging markets. The acquisition
will be included under the Group’s new business category unit Surgical Workflows
and will increase potential for growth in the price sensitive Tier 2 markets in
East/ South Europe and rest of the world. Consolidation of Stericool into
Getinge Group will take place from January 1, 2016. Net sales in 2016 is
estimated at 25 MSEK and EBITDA is expected at 4,5 MSEK.

TSO3 agreement

Getinge has also signed an agreement with TSO3 providing exclusive global
distribution rights for its FDA cleared, STERIZONE VP4 Sterilizer – a dual
sterilant, low temperature sterilization system that utilizes vaporized hydrogen
peroxide and ozone. The STERIZONE VP4 Sterilizer was cleared for
commercialization in the United States in December 2014 and recently received
clearance in Canada to terminally sterilize multichannel flexible endoscopes.
The partnership with TSO3 offers a premium solution for the Tier 1 markets and
immediate sales opportunity in the United States. The five year agreement
includes a one-off license fee amounting to approximately 65 MSEK. Estimated
annual net sales are approximately 430 MSEK by 2020.

-----

For further information, please contact:

Joacim Lindoff

Executive Vice President – Infection Control

Tel: +46 10 335 3999

Scull Zheng

Communications Director – Infection Control

Tel: +46 10 335 5737

About Stericool

Founded in 2008, GOA Teknoloji Danismanlik Elek. Imalat Tic. Ithalat Ihracat
A.S. (Stericool) is a privately held company based in Ankara, Turkey. Based on
new development in close cooperation with local university in Ankara, the
company is dedicated to develop, manufacture, sell and service an affordable
range of low temperature sterilizers based on H2O2 plasma technology. For more
information about Stericool, visit the company website at www.stericool.com

About TSO3

Founded in 1998, TSO3’s activities encompass the sale, production, maintenance,
research, development and licensing of sterilization processes, related
consumable supplies and accessories for heat-sensitive medical devices. The
Company designs products for sterile processing areas in the hospital
environment that offer an advantageous replacement solution to other low
temperature sterilization processes currently used in hospitals. It also offers
services related to the maintenance of sterilization equipment and compatibility
testing of medical devices with such processes. For more information about TSO3,
visit the company's web site at www.tso3.com or contact Liolios Group at (949)
574-3860 or email TOS@liolios.com.

About Getinge Infection Control

Getinge Infection Control (Getinge) is one of three business areas within
Getinge Group, a publicly-listed, Swedish-based group of companies. The Getinge
Infection Control business area consists of two divisions; Healthcare and Life
Science. For the Healthcare sector, Getinge provides solutions for infection
control whereas for the Life Science sector, Getinge is a key provider of
solutions for contamination prevention.

Worldwide, Getinge ranks among the leading providers of washers and sterilizers
within the healthcare and life science segments. Since its foundation in 1904,
Getinge has stood for innovation and technological progress in the field of
washing and sterilization. Together with the other two business areas, Extended
Care (ArjoHuntleigh) and Medical Systems (Maquet), the entire Getinge Group
focuses on state-of-the-art medical technology.

The Getinge Infection Control organization is to be found all over the world,
with 36 subsidiaries on six continents and over 230 distributors and partner
companies in sales and service representing Getinge Infection Control.

Getinge Group is a global leading medical technology company that operates in
the areas of surgery, intensive care, infection control, care ergonomics and
wound care. Getinge Group has nearly 16,000 employees in over 40 countries and
generates sales of almost SEK 27 billion (2014). The Group is divided into three
business areas: Medical Systems, Extended Care and Infection Control and
operates under the brands of Maquet, ArjoHuntleigh and Getinge.

The information is such that Getinge AB must disclose in accordance with the
Swedish Securities Market Act and/or the Financial Instruments Trading Act.